Viviana Bazan

8.8k total citations
191 papers, 6.3k citations indexed

About

Viviana Bazan is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Viviana Bazan has authored 191 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 74 papers in Molecular Biology and 65 papers in Cancer Research. Recurrent topics in Viviana Bazan's work include Cancer Genomics and Diagnostics (39 papers), Lung Cancer Treatments and Mutations (35 papers) and Genetic factors in colorectal cancer (33 papers). Viviana Bazan is often cited by papers focused on Cancer Genomics and Diagnostics (39 papers), Lung Cancer Treatments and Mutations (35 papers) and Genetic factors in colorectal cancer (33 papers). Viviana Bazan collaborates with scholars based in Italy, United States and Belgium. Viviana Bazan's co-authors include Antonio Russo, Daniele Fanale, Nicola Gebbia, Valentina Calò, Sérgio Rizzo, Antonio Galvano, Giuseppe Bronte, Angela Listì, Marcella Macaluso and Francesco Passiglia and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Viviana Bazan

182 papers receiving 6.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Viviana Bazan Italy	42	3.1k	2.7k	2.0k	1.4k	1.1k	191	6.3k
Richie Soong Singapore	49	3.2k 1.0×	2.6k 1.0×	1.6k 0.8×	1.4k 1.0×	1.2k 1.1×	143	6.3k
Mark Basik Canada	41	2.8k 0.9×	3.5k 1.3×	2.9k 1.5×	1.0k 0.7×	1.3k 1.1×	142	7.2k
Charles Lu United States	24	1.7k 0.6×	3.6k 1.3×	2.1k 1.1×	890 0.6×	821 0.7×	49	6.3k
Anne F. Schott United States	32	4.4k 1.4×	2.4k 0.9×	2.5k 1.3×	898 0.6×	581 0.5×	92	7.0k
Cheryl Gillett United Kingdom	45	4.0k 1.3×	4.2k 1.6×	2.4k 1.2×	1.2k 0.9×	1.3k 1.1×	123	8.5k
Bjørn Naume Norway	45	3.4k 1.1×	2.5k 0.9×	3.1k 1.6×	1.1k 0.8×	554 0.5×	134	6.7k
Kaori Shima United States	40	3.2k 1.0×	2.3k 0.8×	1.3k 0.7×	720 0.5×	1.8k 1.5×	81	5.7k
Daniele Generali Italy	42	3.1k 1.0×	2.5k 0.9×	2.1k 1.1×	1.7k 1.2×	499 0.4×	232	6.2k
Ja Seung Koo South Korea	43	2.4k 0.8×	2.7k 1.0×	2.8k 1.4×	807 0.6×	896 0.8×	231	6.3k
Ben Ho Park United States	43	2.5k 0.8×	5.2k 1.9×	2.2k 1.1×	1.5k 1.1×	660 0.6×	142	8.0k

Countries citing papers authored by Viviana Bazan

Since Specialization

Citations

This map shows the geographic impact of Viviana Bazan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viviana Bazan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viviana Bazan more than expected).

Fields of papers citing papers by Viviana Bazan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viviana Bazan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viviana Bazan. The network helps show where Viviana Bazan may publish in the future.

Co-authorship network of co-authors of Viviana Bazan

This figure shows the co-authorship network connecting the top 25 collaborators of Viviana Bazan. A scholar is included among the top collaborators of Viviana Bazan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viviana Bazan. Viviana Bazan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Incorvaia, Lorena, Cláudia Marchetti, Chiara Brando, et al.. (2025). BRCA functional domains associated with high risk of multiple primary tumors and domain-related sensitivity to olaparib: the Prometheus Study. ESMO Open. 10(2). 104076–104076. 2 indexed citations

Incorvaia, Lorena, Tancredi Didier Bazan Russo, Valerio Gristina, et al.. (2024). The intersection of homologous recombination (HR) and mismatch repair (MMR) pathways in DNA repair-defective tumors. npj Precision Oncology. 8(1). 190–190. 10 indexed citations

Incorvaia, Lorena, Chiara Brando, Alessandro Perez, et al.. (2023). Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients.. Journal of Clinical Oncology. 41(16_suppl). 10592–10592.

Peri, Marta, Giuseppe Roberto Giammalva, Antonino Lupica, et al.. (2023). Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis. Diagnostics. 13(1). 144–144. 5 indexed citations

Fanale, Daniele, Lidia Rita Corsini, Chiara Brando, et al.. (2022). Can the tumor-agnostic evaluation of MSI/MMR status be the common denominator for the immunotherapy treatment of patients with several solid tumors?. Critical Reviews in Oncology/Hematology. 170. 103597–103597. 18 indexed citations

Fanale, Daniele, Chiara Brando, Lidia Rita Corsini, et al.. (2022). MUTYH-associated tumor syndrome: The other face of MAP. Oncogene. 41(18). 2531–2539. 19 indexed citations

Fanale, Daniele, Erika Pedone, Chiara Brando, et al.. (2022). Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer. Cancers. 14(18). 4344–4344. 27 indexed citations

Fanale, Daniele, Lorena Incorvaia, Giuseppe Badalamenti, et al.. (2021). Prognostic Role of Plasma PD-1, PD-L1, pan-BTN3As and BTN3A1 in Patients Affected by Metastatic Gastrointestinal Stromal Tumors: Can Immune Checkpoints Act as a Sentinel for Short-Term Survival?. Cancers. 13(9). 2118–2118. 20 indexed citations

Incorvaia, Lorena, Lidia Rita Corsini, Chiara Brando, et al.. (2021). Challenges and advances for the treatment of renal cancer patients with brain metastases: From immunological background to upcoming clinical evidence on immune-checkpoint inhibitors. Critical Reviews in Oncology/Hematology. 163. 103390–103390. 5 indexed citations

10.

Fanale, Daniele, Chiara Brando, Alessia Fiorino, et al.. (2021). POLE, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes. Oncogene. 40(40). 5893–5901. 45 indexed citations

11.

Incorvaia, Lorena, Daniele Fanale, Bruno Vincenzi, et al.. (2021). Type and Gene Location of KIT Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon. Cancers. 13(5). 993–993. 8 indexed citations

12.

Fanale, Daniele, Lorena Incorvaia, Clarissa Filorizzo, et al.. (2020). Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond BRCA1/2. Cancers. 12(9). 2415–2415. 35 indexed citations

13.

Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, et al.. (2020). Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)—Prevalence and Geographic Distribution of Pathogenic Variants in BRCA1/2 Genes. Cancers. 12(5). 1158–1158. 24 indexed citations

14.

Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, et al.. (2020). A “Lymphocyte MicroRNA Signature” as Predictive Biomarker of Immunotherapy Response and Plasma PD-1/PD-L1 Expression Levels in Patients with Metastatic Renal Cell Carcinoma: Pointing towards Epigenetic Reprogramming. Cancers. 12(11). 3396–3396. 31 indexed citations

15.

Incorvaia, Lorena, Daniele Fanale, Giuseppe Badalamenti, et al.. (2020). Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions. OncoImmunology. 9(1). 1832348–1832348. 55 indexed citations

16.

Badalamenti, Giuseppe, Nadia Barraco, Lorena Incorvaia, et al.. (2019). Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)? The Role of H19 and MALAT1. Journal of Oncology. 2019. 1–7. 12 indexed citations

17.

Badalamenti, Giuseppe, Daniele Fanale, Lorena Incorvaia, et al.. (2018). Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?. Cellular Immunology. 343. 103753–103753. 167 indexed citations

18.

Fanale, Daniele, Giuseppe Bronte, Francesco Passiglia, et al.. (2015). Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?. Analytical Cellular Pathology. 2015. 1–19. 95 indexed citations

19.

Veschi, Serena, Gitana María Aceto, Valentina Gatta, et al.. (2007). High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. Annals of Oncology. 18. vi86–vi92. 20 indexed citations

20.

Russo, Antonio, Manuela Migliavacca, Ines Zanna, et al.. (2002). p53 Mutations in L3-Loop Zinc-binding Domain, DNA-Ploidy, and S Phase Fraction Are Independent Prognostic Indicators in Colorectal Cancer. Cancer Epidemiology and Prevention Biomarkers. 11(11). 1322–1331. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact